CRI: Engineering Intrinsic AAV Proteins for Safer Gene Therapies
Engineering Intrinsic AAV Proteins for Safer Gene Therapies
Join the Children's Research Institute and Sarah Powell, PhD, an assistant professor in the UNC School of Medicine Department of Pediatrics, for a seminar on engineering intrinsic Adeno-associated virus (AAV) proteins for safer gene therapies. AAV is the vector of choice for gene therapy treatments, partially as a result of decades of research on its biology at UNC-Chapel Hill. Now that the therapeutic potential of gene therapy and AAV gene therapy has been realized, a greater understanding of the virus is required to generate safer, more efficacious treatments. Powell studies intrinsic AAV proteins and their potential roles in AAV biology that can be applied to AAV gene therapies in the Central Nervous System (CNS).
Participate in the seminar at 3116 Mary Ellen Jones Building (with lunch provided). A zoom option is available by request.